OR WAIT null SECS
December 14, 2020
EUA marks a milestone in COVID-19 vaccine development and is hailed as a turning point in pandemic fight.
December 11, 2020
Success in combatting the pandemic depends on the ability of manufacturers to quickly and efficiently produce and distribute the huge quantities of vaccines demanded by the United States government and public health organizations around the world.
Committee recommends Emergency Use Authorization of first mRNA-based COVID-19 vaccine; FDA approval is pending.
December 10, 2020
Evonik offers lipid nanoparticles for gene-based drug development and manufacturing.
December 09, 2020
The company has received $500 million in funding from Sino Biopharmaceutical for further development, capacity expansion, and manufacturing of CoronaVac, its COVID-19 vaccine candidate.
CDMO HALIX will manufacture the drug substance for AstraZeneca’s COVID-19 vaccine candidate, AZD1222, at commercial scale at its cGMP facility in the Netherlands.
December 08, 2020
The company will expand its micronization abilities for highly potent drug compounds through this investment.
A development agreement will study inhaled formulations of cannabinoid-based drug product for central nervous system diseases.
December 03, 2020
Janssen announces rolling submissions for its COVID-19 vaccine with Health Canada and EMA.
Operator, caregiver, and patient safety are at the forefront when selecting the best options and dosage forms.